HOME >> BIOLOGY >> NEWS
DNA registry to study links among genetics, environment, disease

CHAPEL HILL -- Scientists at the University of North Carolina at Chapel Hill and the National Institute of Environmental Health Sciences (NIEHS) are developing a voluntary DNA registry to study the link among environmental exposures, genetic susceptibility and human disease.

Eventually to include 20,000 patients at various UNC medical facilities, the Environmental Polymorphism Registry will be unlike the many anonymous DNA repositories that have developed since the advent and recent completion of the human genome initiatives - in that patient identifiers will be maintained in coded form.

This innovation will allow scientists to contact registry participants at a later date for their permission to obtain additional information, to invite their participation in additional studies and to offer them the option to drop out of the registry. Currently, no similar resources are available to the National Institutes of Health or to researchers at UNC.

"This is a pioneering initiative," said Dr. Paul B. Watkins, professor of medicine and director of the university's Caviness General Clinical Research Center. "Clearly, this is the next step that's needed to increase our understanding of how genes interact with the environment, including the body's response to medicines."

The registry was initiated by Dr. Perry Blackshear, NIEHS director of clinical research, and Dr. Patricia Chulada, health science administrator at the institute in Research Triangle Park. Also collaborating with Watkins at UNC is Susan Pusek, General Clinical Research Center director of training and career development.

Data from follow-up studies will help scientists identify groups of individuals with genetic polymorphisms, or variants, in "environmentally sensitive" genes and possibly to correlate these genetic variants with clinical histories and current health status.

These genes control how the human body interacts with substances from the environment, encoding pro
'"/>

Contact: Leslie Lang
llang@med.unc.edu
919-843-9687
University of North Carolina School of Medicine
8-Jan-2004


Page: 1 2

Related biology news :

1. NIEHS and UNC to collaborate on registry of 20,000 subjects
2. ART laws put patients at risk and should be changed, warns head of Germanys IVF registry
3. UNC, other physicians setting up national registry
4. Israeli fertility experts call for international chromosome registry
5. K-State veterinarians lab site for DNA registry
6. Student science contest participation influences study, career choices, alumni say
7. New study shows hope for treating inhalant abuse
8. International study findings link acne-like rash to effectiveness of new targeted cancer treatment
9. Cigarette smoke causes breaks in DNA and defects to a cells chromosomes, Pitt study finds
10. New study indicates arsenic could be suitable as first-line treatment in type of leukaemia
11. Phase II trials of second-generation antisense cancer drug planned following successful early study

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/8/2016)... , March 8, 2016   Valencell ... technology, today announced it has secured $11M in ... GII Tech, a new venture fund being launched ... additional participation from existing investors TDF Ventures and ... funds to continue its triple-digit growth and accelerate ...
(Date:3/3/2016)... MONTEREY, Calif. , March 3, 2016 /PRNewswire/ ... Partner, launched this week highlighting advancements in flexible, ... – a record setting attendance - have gathered ... in this fast-growing field of electronics. The Flex ... a focal point for companies, R&D organizations, and ...
(Date:3/2/2016)... March 2, 2016 ... addition of the  "Global Biometrics Market in ... ,     (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , , Global biometrics ... at a CAGR of around 27%   ... has announced the addition of the  "Global ...
Breaking Biology News(10 mins):
(Date:5/4/2016)... N.J. , May 4, 2016  Bayer ... its oncology compound Stivarga ® (regorafenib) tablets ... carcinoma (HCC) has met its primary endpoint of ... study, called RESORCE, evaluated the efficacy and safety ... has progressed after treatment with sorafenib. The safety ...
(Date:5/4/2016)... New York, NY (PRWEB) , ... May 04, ... ... growth, has leveraged recent innovations in biotechnology to help treat hormonal and stress ... hair loss, Nutrafol® has captured the hearts of key opinion leaders in the ...
(Date:5/3/2016)... ... 03, 2016 , ... Leading CEOs from biotech, pharmaceutical, and ... June 1st at The Four Seasons Hotel Boston. , The Boston CEO Conference ... exclusive access to key decision makers who influence deal making and investment. Attendees ...
(Date:5/3/2016)... -- - And Other Rising Companies - ... Competitor Biologics  - Biosimilar Drug Producers - ... Who are the most important and promising ... sales potentials? Discover, in our updated survey, organisations, outlooks ... revenue forecasting. Visiongain,s new study ...
Breaking Biology Technology:
Cached News: